About Grid Therapeutics
Grid Therapeutics is a private company based in Durham, North Carolina. It has reported $8,189,818 raised in three offerings on Form D since March 2018. Its chief executive is Edward Patz, Jr..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2022 | Jan 5, 2023 | $1,740,000fully sold | 11 | $158K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 12, 2020 | Dec 9, 2020 | $1,909,367of $5.0M target | 7 | $272K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 15, 2018 | Mar 29, 2018 | $4,540,451of $5.0M target | 12 | $378K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $8,189,818 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Grid Therapeutics's Form D filed Jan 5, 2023.
KS
Kevin Schulman
Director
TP
Thomas Patz
Executive officer and director
EJ
Edward Patz, Jr.
CEO and director
SL
Scott Lyman
Executive officer
PP
Paolo Paoletti
Director
RP
Richard Parker
Director